Company: ABBV
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001551152-25-000029
Chunk: 43

Company: AbbVie Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 basis in order to achieve established long-term strategic goals. Consistent with this structure, a global research and development and supply chain organization is responsible for the discovery, manufacturing and supply of products. Commercial efforts that coordinate the marketing, sales and distribution of these products are organized by geographic region or therapeutic area. All of these activities are supported by a global corporate administrative staff. The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the CODM for purposes of assessing performance, allocating resources and planning and forecasting future periods. 

The CODM regularly reviews net revenues, net earnings and significant segment expenses and uses net earnings as its principal measure of segment profit or loss. Net earnings and significant segment expenses reviewed by CODM are reported on the condensed consolidated statements of earnings for the periods ended March 31, 2025 and 2024. The CODM uses net earnings as its principal measure of segment profit or loss to compare past financial performance with current performance and analyze underlying business performance and trends. The CODM does not use segment assets to make decisions regarding resources; therefore, the total asset disclosure has not been included.The following table details AbbVie’s worldwide net revenues:Three months endedMarch 31,(in millions)20252024ImmunologySkyriziUnited States$2,919 $1,656 International506 352 Total$3,425 $2,008 RinvoqUnited States$1,220 $725 International498 368 Total$1,718 $1,093 HumiraUnited States$744 $1,771 International377 499 Total$1,121 $2,270 NeuroscienceVraylarUnited States$763 $692 International2 2 Total$765 $694 Botox TherapeuticUnited States$723 $611 International143 137 Total$866 $748 UbrelvyUnited States$233 $197 International7 6 Total$240 $203 QuliptaUnited States$172 $128 International21 3 Total$193 $131 VyalevUnited States$6 $— International57 9 Total$63 $9 DuodopaUnited States$20 $25 International76 90 Total$96 $115 Other NeuroscienceUnited States$55 $61 International4 4 Total$59 $65